<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02039427</url>
  </required_header>
  <id_info>
    <org_study_id>YUH-3368-sore throat</org_study_id>
    <nct_id>NCT02039427</nct_id>
  </id_info>
  <brief_title>The Effect of Prophylactic Ketorolac on Sore Throat After Thyroid Surgery</brief_title>
  <official_title>The Effect of Prophylactic Ketorolac on Sore Throat After Thyroid Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yeungnam University College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yeungnam University College of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sore throat is one of most frequent complaints related to general anesthesia with tracheal
      intubation. Although sore throat is regarded as a minor and short-lasting discomfort after
      surgery, its incidence and intensity in high risk patients such as female gender, head and
      neck surgery and difficult laryngoscopy or intubation may attribute to prolong postoperative
      recovery and give patient dissatisfaction.

      Even though the pathophysiology of post-intubation airway symptoms is not completely
      clarified yet, the mucosal damage related inflammation at the cuff of endotracheal tube has
      been thought to be an essential trigger. Thus anti-inflammatory medication has been commonly
      used strategy to prevent postoperative airway discomfort after intubation. The preoperative
      administration of dexamethasone has been reported to reduce the incidence and severity of
      postoperative sore throat, but it is accompanied with the adverse effects such as
      hyperglycemia, delayed wound healing and increased infection in surgical patients. Ketorolac,
      non-steroidal anti-inflammatory drug (NSAID), is an analgesic that commonly used for
      postoperative pain control and has anti-inflammatory effect.

      Therefore, the investigator designed to evaluate the effect of ketorolac on sore throat in
      comparison to dexamethasone after thyroidectomy in female adult patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ketorolac, NSAID, has not been evaluated as a pharmacologic strategy to reduce postoperative
      sore throat yet. The investigator will explore how the analgesic and anti-inflammatory
      effects of ketorolac influence airway symptoms following general anesthesia with tracheal
      intubation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Incidence of Postoperative Sore Throat(POST) Using Ketorolac and Dexamethasone in Womend After Thyroidectomy</measure>
    <time_frame>at 1, 6 and 24 hours after thyroidectomy</time_frame>
    <description>The investigator asked scales to patients at 1, 6 and 24h after extubation. POST was defined as discomfort at larynx or pharynx at rest and during swallowing after surgery and was assessed using a 4-grade scale (0-3) based on verbal responses to questions: 0, none; 1, mild (less severe than with a cold); 2, moderate (similar with a cold); 3 severe (more severe than with a cold)
● Incidence of sore throat : if patient rates sore throat scale more than 1, investigator will record as positive symptom.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Incidence of Postoperative Hoarseness(PH) Using Ketorolac and Dexamethasone in Womend After Thyroidectomy</measure>
    <time_frame>at 1, 6 and 24 hours after thyroidectomy</time_frame>
    <description>The investigator asked scales to patients at 1, 6 and 24h after extubation. PH was assessed using a 4-grade scale (0-3): 0, none; 1, mild (noticed by the patient only); 2, severe (obvious to observer); 3 aphonia (silence of voice)
● Incidence of hoarseness: If patient exhibit hoarseness scale more than 1, investigator will record as positive sign</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Potential Side Effects Associated With the Study Drugs</measure>
    <time_frame>at 1, 6 and 24 hours after extubation</time_frame>
    <description>Potential side effects associated with the study drugs, such as anlgesic use, nausea and vomiting.</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">192</enrollment>
  <condition>Anesthesia Intubation Complication</condition>
  <condition>Tracheal Disease</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline(Placebo) 2 ml 5 min before induction Normal saline 2 ml 10 min before end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preketorolac</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ketorolac 30 mg 5 min before induction Normal saline 2 ml 10 min before end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Postketorolac</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Normal saline 2 ml 5 min before induction Ketorolac 30 mg 10 min before end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexamethasone 10 mg (total volume 2 ml) 5 min before induction Normal saline 2 ml 10 min before end of surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketorolac</intervention_name>
    <description>ketorolac 30 mg mixed with normal saline 1 ml : total volume of 2 ml</description>
    <arm_group_label>Preketorolac</arm_group_label>
    <arm_group_label>Postketorolac</arm_group_label>
    <other_name>Kerola</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>dexamethasone acetate10 mg : total volume of 2 ml</description>
    <arm_group_label>Dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Normal saline 2 ml</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. American society of Anesthesiologists(ASA) physical status 1 and 2

          2. 20-60 years old female

          3. elective scheduled thyroidectomy

        Exclusion Criteria:

        surgery longer than 3 hours Previous history of or expected difficult tracheal intubation
        Laryngoscope grade (by Cormack and Lehane) of 3 or 4 2 more trial for intubation BMI &gt; 30
        Hypersensitivity to ketorolac history of asthma respiratory tract infection during the past
        6 weeks Renal dysfunction (creatinine &gt; 1.5 mg/dl or oligouria) Hepatic dysfunction (ALT :&gt;
        50% more than normal value) Use of corticosteroid, NSAIDS, angiotensin converting enzyme in
        10 days Medication for gastritis, gastric ulcer Upper gastrointestinal bleeding history
        Diabetes mellitus
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sung Mee Jung, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yeungnam University College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yeungnam University Hospital</name>
      <address>
        <city>Daegu</city>
        <zip>705-717</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/15892411</url>
    <description>Complaints of sore throat after tracheal intubation: a prospective evaluation</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed?linkname=pubmed_pubmed&amp;from_uid=15892411</url>
    <description>Gender differences in risk factors for airway symptoms following tracheal intubation</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/24357270</url>
    <description>Dexamethasone for preventing postoperative sore throat: a meta-analysis of randomized controlled trials</description>
  </link>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2014</study_first_submitted>
  <study_first_submitted_qc>January 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 17, 2014</study_first_posted>
  <results_first_submitted>December 7, 2016</results_first_submitted>
  <results_first_submitted_qc>April 18, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">July 31, 2017</results_first_posted>
  <last_update_submitted>July 30, 2017</last_update_submitted>
  <last_update_submitted_qc>July 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yeungnam University College of Medicine</investigator_affiliation>
    <investigator_full_name>Sung Mee Jung</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Sore throat</keyword>
  <keyword>Hoarseness</keyword>
  <keyword>Intubation</keyword>
  <keyword>Thyroidectomy</keyword>
  <keyword>Ketorolac</keyword>
  <keyword>Dexamethasone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharyngitis</mesh_term>
    <mesh_term>Tracheal Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Ketorolac Tromethamine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>This study was conducted Yeungnam University Hospital in South korea from Oct. 2013 to Oct. 2015. One hundred and ninety - two female adults aged between 20 and 65 years, ASA physical status I or II scheduled for elective primary thyroidectomy under general anesthesia were enrolled.</recruitment_details>
      <pre_assignment_details>Patients with a airway problem, recent upper respiratory tract infection, obese, inflammation or hemorrhage in the upper gastrointestinal tract, use of NSAID or steroid medication, allergy to the general anesthetic used in this study were excluded.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Normal saline(Placebo) 2 ml at 5 min before induction and Normal saline(Placebo) 2 ml at 10 min before end of surgery
Placebo: Normal saline 2 ml</description>
        </group>
        <group group_id="P2">
          <title>Preketorolac</title>
          <description>Ketorolac 30 mg at 5 min before induction and Normal saline(Placebo) 2 ml at 10 min before end of surgery
Ketorolac: ketorolac 30 mg mixed with normal saline 1 ml : total volume of 2 ml</description>
        </group>
        <group group_id="P3">
          <title>Postketorolac</title>
          <description>Normal saline(Placebo) 2 ml at 5 min before induction and Ketorolac 30 mg at 10 min before end of surgery
Ketorolac: ketorolac 30 mg mixed with normal saline 1 ml : total volume of 2 ml</description>
        </group>
        <group group_id="P4">
          <title>Dexamethasone</title>
          <description>Dexamethasone 10 mg at 5 min before induction and Normal saline(Placebo) 2 ml at 10 min before end of surgery
Dexamethasone: dexamethasone acetate 10 mg mixed with normal saline : total volume of 2 ml</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="48"/>
                <participants group_id="P3" count="48"/>
                <participants group_id="P4" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="47"/>
                <participants group_id="P3" count="45"/>
                <participants group_id="P4" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Duration of surgery &gt; 3h</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal on concent</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Cancellation of surgery</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Loss of follow - up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Steroid Use</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>Normal saline(Placebo) 2 ml 5 min before induction Normal saline 2 ml 10 min before end of surgery
Placebo: Normal saline 2 ml</description>
        </group>
        <group group_id="B2">
          <title>Preketorolac</title>
          <description>Ketorolac 30 mg 5 min before induction Normal saline 2 ml 10 min before end of surgery
Ketorolac: ketorolac 30 mg mixed with normal saline 1 ml : total volume of 2 ml</description>
        </group>
        <group group_id="B3">
          <title>Postketorolac</title>
          <description>Normal saline 2 ml 5 min before induction Ketorolac 30 mg 10 min before end of surgery
Ketorolac: ketorolac 30 mg mixed with normal saline 1 ml : total volume of 2 ml</description>
        </group>
        <group group_id="B4">
          <title>Dexamethasone</title>
          <description>Dexamethasone 10 mg (total volume 2 ml) 5 min before induction Normal saline 2 ml 10 min before end of surgery
Dexamethasone: dexamethasone acetate10 mg : total volume of 2 ml</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="45"/>
            <count group_id="B2" value="47"/>
            <count group_id="B3" value="45"/>
            <count group_id="B4" value="43"/>
            <count group_id="B5" value="180"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="45"/>
                    <measurement group_id="B4" value="43"/>
                    <measurement group_id="B5" value="180"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48.2" spread="10.1"/>
                    <measurement group_id="B2" value="49.5" spread="9.2"/>
                    <measurement group_id="B3" value="47.3" spread="9.3"/>
                    <measurement group_id="B4" value="46.0" spread="11.1"/>
                    <measurement group_id="B5" value="47.8" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="45"/>
                    <measurement group_id="B4" value="43"/>
                    <measurement group_id="B5" value="180"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Incidence of Postoperative Sore Throat(POST) Using Ketorolac and Dexamethasone in Womend After Thyroidectomy</title>
        <description>The investigator asked scales to patients at 1, 6 and 24h after extubation. POST was defined as discomfort at larynx or pharynx at rest and during swallowing after surgery and was assessed using a 4-grade scale (0–3) based on verbal responses to questions: 0, none; 1, mild (less severe than with a cold); 2, moderate (similar with a cold); 3 severe (more severe than with a cold)
● Incidence of sore throat : if patient rates sore throat scale more than 1, investigator will record as positive symptom.</description>
        <time_frame>at 1, 6 and 24 hours after thyroidectomy</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Normal saline(Placebo) 2 ml 5 min before induction Normal saline 2 ml 10 min before end of surgery
Placebo: Normal saline 2 ml</description>
          </group>
          <group group_id="O2">
            <title>Preketorolac</title>
            <description>Ketorolac 30 mg 5 min before induction Normal saline 2 ml 10 min before end of surgery
Ketorolac: ketorolac 30 mg mixed with normal saline 1 ml : total volume of 2 ml</description>
          </group>
          <group group_id="O3">
            <title>Postketorolac</title>
            <description>Normal saline 2 ml 5 min before induction Ketorolac 30 mg 10 min before end of surgery
Ketorolac: ketorolac 30 mg mixed with normal saline 1 ml : total volume of 2 ml</description>
          </group>
          <group group_id="O4">
            <title>Dexamethasone</title>
            <description>Dexamethasone 10 mg (total volume 2 ml) 5 min before induction Normal saline 2 ml 10 min before end of surgery
Dexamethasone: dexamethasone acetate10 mg : total volume of 2 ml</description>
          </group>
        </group_list>
        <measure>
          <title>The Incidence of Postoperative Sore Throat(POST) Using Ketorolac and Dexamethasone in Womend After Thyroidectomy</title>
          <description>The investigator asked scales to patients at 1, 6 and 24h after extubation. POST was defined as discomfort at larynx or pharynx at rest and during swallowing after surgery and was assessed using a 4-grade scale (0–3) based on verbal responses to questions: 0, none; 1, mild (less severe than with a cold); 2, moderate (similar with a cold); 3 severe (more severe than with a cold)
● Incidence of sore throat : if patient rates sore throat scale more than 1, investigator will record as positive symptom.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="47"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Sore throat Rest at 1h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="44"/>
                    <measurement group_id="O3" value="42"/>
                    <measurement group_id="O4" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sore throat Rest at 6h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="34"/>
                    <measurement group_id="O3" value="33"/>
                    <measurement group_id="O4" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sore throat Rest at 24h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="25"/>
                    <measurement group_id="O4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sore throat Swallowing at 1h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="45"/>
                    <measurement group_id="O3" value="44"/>
                    <measurement group_id="O4" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sore throat Swallowing at 6h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="42"/>
                    <measurement group_id="O3" value="40"/>
                    <measurement group_id="O4" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sore throat Swallowing at 24h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                    <measurement group_id="O2" value="37"/>
                    <measurement group_id="O3" value="37"/>
                    <measurement group_id="O4" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Incidence of Postoperative Hoarseness(PH) Using Ketorolac and Dexamethasone in Womend After Thyroidectomy</title>
        <description>The investigator asked scales to patients at 1, 6 and 24h after extubation. PH was assessed using a 4-grade scale (0–3): 0, none; 1, mild (noticed by the patient only); 2, severe (obvious to observer); 3 aphonia (silence of voice)
● Incidence of hoarseness: If patient exhibit hoarseness scale more than 1, investigator will record as positive sign</description>
        <time_frame>at 1, 6 and 24 hours after thyroidectomy</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Normal saline(Placebo) 2 ml 5 min before induction Normal saline 2 ml 10 min before end of surgery
Placebo: Normal saline 2 ml</description>
          </group>
          <group group_id="O2">
            <title>Preketorolac</title>
            <description>Ketorolac 30 mg 5 min before induction Normal saline 2 ml 10 min before end of surgery
Ketorolac: ketorolac 30 mg mixed with normal saline 1 ml : total volume of 2 ml</description>
          </group>
          <group group_id="O3">
            <title>Postketorolac</title>
            <description>Normal saline 2 ml 5 min before induction Ketorolac 30 mg 10 min before end of surgery
Ketorolac: ketorolac 30 mg mixed with normal saline 1 ml : total volume of 2 ml</description>
          </group>
          <group group_id="O4">
            <title>Dexamethasone</title>
            <description>Dexamethasone 10 mg (total volume 2 ml) 5 min before induction Normal saline 2 ml 10 min before end of surgery
Dexamethasone: dexamethasone acetate10 mg : total volume of 2 ml</description>
          </group>
        </group_list>
        <measure>
          <title>The Incidence of Postoperative Hoarseness(PH) Using Ketorolac and Dexamethasone in Womend After Thyroidectomy</title>
          <description>The investigator asked scales to patients at 1, 6 and 24h after extubation. PH was assessed using a 4-grade scale (0–3): 0, none; 1, mild (noticed by the patient only); 2, severe (obvious to observer); 3 aphonia (silence of voice)
● Incidence of hoarseness: If patient exhibit hoarseness scale more than 1, investigator will record as positive sign</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="47"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hoarseness at 1h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                    <measurement group_id="O2" value="44"/>
                    <measurement group_id="O3" value="40"/>
                    <measurement group_id="O4" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hoarseness at 6h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="36"/>
                    <measurement group_id="O3" value="39"/>
                    <measurement group_id="O4" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hoarseness at 24h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="28"/>
                    <measurement group_id="O3" value="29"/>
                    <measurement group_id="O4" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Potential Side Effects Associated With the Study Drugs</title>
        <description>Potential side effects associated with the study drugs, such as anlgesic use, nausea and vomiting.</description>
        <time_frame>at 1, 6 and 24 hours after extubation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Normal saline(Placebo) 2 ml at 5 min before induction and Normal saline(Placebo) 2 ml at 10 min before end of surgery
Placebo: Normal saline 2 ml</description>
          </group>
          <group group_id="O2">
            <title>Preketorolac</title>
            <description>Ketorolac 30 mg at 5 min before induction and Normal saline(Placebo) 2 ml at 10 min before end of surgery
Ketorolac: ketorolac 30 mg mixed with normal saline 1 ml : total volume of 2 ml</description>
          </group>
          <group group_id="O3">
            <title>Postketorolac</title>
            <description>Normal saline(Placebo) 2 ml at 5 min before induction and Ketorolac 30 mg at 10 min before end of surgery
Ketorolac: ketorolac 30 mg mixed with normal saline 1 ml : total volume of 2 ml</description>
          </group>
          <group group_id="O4">
            <title>Dexamethasone</title>
            <description>Dexamethasone 10 mg at 5 min before induction and Normal saline(Placebo) 2 ml at 10 min before end of surgery
Dexamethasone: dexamethasone acetate 10 mg mixed with normal saline : total volume of 2 ml</description>
          </group>
        </group_list>
        <measure>
          <title>Potential Side Effects Associated With the Study Drugs</title>
          <description>Potential side effects associated with the study drugs, such as anlgesic use, nausea and vomiting.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="47"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Analgesic use at 1h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Analgesic use at 6h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Analgesic use at 24h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea at 1h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea at 6h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea at 24h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting at 1h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting at 6h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting at 24h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1h, 6h and 24h after surgery</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>Normal saline(Placebo) 2 ml 5 min before induction Normal saline 2 ml 10 min before end of surgery
Placebo: Normal saline 2 ml</description>
        </group>
        <group group_id="E2">
          <title>Preketorolac</title>
          <description>Ketorolac 30 mg 5 min before induction Normal saline 2 ml 10 min before end of surgery
Ketorolac: ketorolac 30 mg mixed with normal saline 1 ml : total volume of 2 ml</description>
        </group>
        <group group_id="E3">
          <title>Postketorolac</title>
          <description>Normal saline 2 ml 5 min before induction Ketorolac 30 mg 10 min before end of surgery
Ketorolac: ketorolac 30 mg mixed with normal saline 1 ml : total volume of 2 ml</description>
        </group>
        <group group_id="E4">
          <title>Dexamethasone</title>
          <description>Dexamethasone 10 mg (total volume 2 ml) 5 min before induction Normal saline 2 ml 10 min before end of surgery
Dexamethasone: dexamethasone acetate10 mg : total volume of 2 ml</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="43"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="43"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="43"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The present study has some limitations. First, the dose of dexamethasone and ketorolac may not be equipotent in terms of anti-inflammatory efficacy. Second, postoperative pain control might affect the incidence and severity of the POST.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Sung Mee Jung, M.D</name_or_title>
      <organization>Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Daegu, Republic of Korea</organization>
      <phone>+82-53-620-3368</phone>
      <email>applejsm@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

